Radcliffe Capital Management’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-46,100
Closed -$440K 956
2021
Q2
$440K Buy
+46,100
New +$104K 0.01% 861

Other funds holding ATIP.WS

Radcliffe Capital Management's ATIP.WS Position: Q3 2021 in Review

Radcliffe Capital Management sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q3 2021, closing a stake of 46,100 shares — an estimated $440K sold.

Radcliffe Capital Management first reported a position in ATIP.WS in Q2 2021 and held it in 1 quarter. The position peaked at $440K in Q2 2021. 20 funds tracked by Wall St. Rank hold ATIP.WS as of Q3 2021.

  • Radcliffe Capital Management reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q3 2021 after selling out during the quarter.
  • Radcliffe Capital Management sold 46,100 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q3 2021, an estimated $440K.
  • Radcliffe Capital Management first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 1 quarter.
  • Radcliffe Capital Management's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $440K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q3 2021.

Based on Radcliffe Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.